{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:17:53Z","timestamp":1790957873171,"version":"4.1.0"},"reference-count":148,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia","award":["RG24-L07"],"award-info":[{"award-number":["RG24-L07"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Alzheimer's disease (AD) remains a significant global health challenge, characterized by its progressive neurodegeneration and cognitive decline. The urgent need for early diagnosis and effective treatment necessitates the identification of reliable biomarkers that can illuminate the underlying pathophysiology of AD. This review provides a comprehensive overview of the latest advancements in biomarker research, focusing on their applications in diagnosis, prognosis, and therapeutic development. We delve into the multifaceted landscape of AD biomarkers, encompassing molecular, imaging, and fluid-based markers. The integration of these biomarkers, including amyloid-\u03b2 and tau proteins, neuroimaging modalities, cerebrospinal fluid analysis, and genetic risk factors, offers a more nuanced understanding of AD's complex etiology. By leveraging the power of precision medicine, biomarker-driven approaches can enable personalized treatment strategies and enhance diagnostic accuracy. Moreover, this review highlights the potential of biomarker research to accelerate drug discovery and development. By identifying novel therapeutic targets and monitoring disease progression, biomarkers can facilitate the evaluation of experimental treatments and ultimately improve patient outcomes. In conclusion, this review underscores the critical role of biomarkers in advancing our comprehension of AD and driving the development of effective interventions. By providing a comprehensive overview of the current state-of-the-art, this work aims to inspire future research and contribute to the goal of conquering AD.<\/jats:p>","DOI":"10.1177\/13872877251330500","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T03:27:06Z","timestamp":1745206026000},"page":"679-696","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Key biomarkers in Alzheimer\u2019s disease: Insights for diagnosis and treatment strategies"],"prefix":"10.1177","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4378-6800","authenticated-orcid":false,"given":"Ruqaiya","family":"Jamal","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Maulana Azad University, Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7988-5950","authenticated-orcid":false,"given":"Mohammad Abuzar","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, AIKTC School of Pharmacy, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5201-3503","authenticated-orcid":false,"given":"Mohamad","family":"Taleuzzaman","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Maulana Azad University, Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6322-3485","authenticated-orcid":false,"given":"Ziyaul","family":"Haque","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Maulana Azad University, Jodhpur, Rajasthan, India"},{"name":"Department of Pharmaceutical Chemistry, AIKTC School of Pharmacy, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8687-0573","authenticated-orcid":false,"given":"Mohammed","family":"Albratty","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9127-5023","authenticated-orcid":false,"given":"Md Shamsher","family":"Alam","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1078-2478","authenticated-orcid":false,"given":"Hafiz A","family":"Makeen","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Research Unit, Department of Clinical \rPharmacy, College of Pharmacy, Jazan University, Jazan, \rSaudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-5227","authenticated-orcid":false,"given":"Khalid","family":"Zoghebi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8978-4670","authenticated-orcid":false,"given":"Safaa Fathy","family":"Saleh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-022-00338-8"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1072994"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006189"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13439"},{"key":"e_1_3_4_7_2","article-title":"Plasma tau in Alzheimer disease","volume":"92","author":"Mattsson N","year":"2019","unstructured":"Mattsson N, Zetterberg H, Janelidze S, et al. Plasma tau in Alzheimer disease. Neurology 2019; 92: e1497\u2013e1506.","journal-title":"Neurology"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12328"},{"key":"e_1_3_4_9_2","volume-title":"World Alzheimer Report 2020. Design, dignity, dementia: Dementia-related design and the built environment","author":"Zeisel J","year":"2020","unstructured":"Zeisel J, Bennett K, Fleming R. World Alzheimer Report 2020. Design, dignity, dementia: Dementia-related design and the built environment. London: Alzheimer\u2019s Disease International, 2020."},{"key":"e_1_3_4_10_2","first-page":"135","article-title":"Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease","volume":"2","author":"Morris GP","year":"2014","unstructured":"Morris GP, Clark IA, Vissel B. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease. Acta Neuropathol Commun 2014; 2: 135.","journal-title":"Acta Neuropathol Commun"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01154"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180802"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3505"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606210"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2494"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3028"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/416535a"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.12.1791"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00391-w"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2967"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"e_1_3_4_22_2","first-page":"136","article-title":"Apolipoprotein E mediates amyloid-\u03b2 clearance from the central nervous system in an isoform-dependent manner","volume":"6","author":"Bateman RJ","year":"2000","unstructured":"Bateman RJ, Holtzman DM. Apolipoprotein E mediates amyloid-\u03b2 clearance from the central nervous system in an isoform-dependent manner. Nat Med 2000; 6: 136\u2013138.","journal-title":"Nat Med"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20009"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12816"},{"key":"e_1_3_4_25_2","article-title":"Recent publications from the Alzheimer's disease neuroimaging initiative: reviewing progress toward improved AD clinical trials","volume":"13","author":"Weiner MW","year":"2017","unstructured":"Weiner MW, Veitch DP, Aisen PS, et al. Recent publications from the Alzheimer's disease neuroimaging initiative: reviewing progress toward improved AD clinical trials. Alzheimers Dement 2017; 13: e1\u2013e85.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.01.002"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature19323"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0079-7"},{"key":"e_1_3_4_30_2","first-page":"2253","article-title":"Tauopathies","volume":"78","author":"Avila J","year":"2021","unstructured":"Avila J, Hern\u00e1ndez F. Tauopathies. Cell Mol Life Sci 2021; 78: 2253\u20132254.","journal-title":"Cell Mol Life Sci"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006247"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.225"},{"key":"e_1_3_4_33_2","first-page":"77","article-title":"A century of Alzheimer's disease","volume":"365","author":"Goedert M","year":"2019","unstructured":"Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2019; 365: 77\u201378.","journal-title":"Science"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00308809"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2015.1"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0188-12.2012"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/31508"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1259-1"},{"key":"e_1_3_4_39_2","first-page":"1152","article-title":"A\u03b2- and tau-positive amyloid PET imaging in Alzheimer's disease","volume":"13","author":"Villemagne VL","year":"2017","unstructured":"Villemagne VL, Dore V, Bourgeat P, et al. A\u03b2- and tau-positive amyloid PET imaging in Alzheimer's disease. Alzheimers Dement 2017; 13: 1152\u20131161.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0755-1"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70090-5"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2420"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi1016233"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2018.12.004"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3363-z"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.01.028"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.05.2243"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.4829"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24546"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz090"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24711"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2016.02.079"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt155"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2009.215"},{"key":"e_1_3_4_55_2","first-page":"1591","article-title":"Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment","volume":"45","author":"Apostolova LG","year":"2007","unstructured":"Apostolova LG, Thompson PM. Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. Neuropsychologia 2007; 45: 1591\u20131602.","journal-title":"Neuropsychologia"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2177-05.2005"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4437-12.2013"},{"key":"e_1_3_4_58_2","first-page":"3076","article-title":"GWAS Of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP","volume":"137","author":"Ramanan VK","year":"2014","unstructured":"Ramanan VK, Risacher SL, Nho K, et al. GWAS Of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. Brain 2014; 137: 3076\u20133084.","journal-title":"Brain"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2017.04.025"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22315"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.12917"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70299-6"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.4.441"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2008.01.010"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2012.06.014"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2012.11.008"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70158-2"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2006.01.021"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.10.081"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.7.1397"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2250-06.2006"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31823efc6c"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.08.024"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.57.3.339"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2005.12.013"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.03.026"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e3182163b62"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2017.02.058"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-210677"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.4"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8259-0"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70355-6"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1064"},{"key":"e_1_3_4_85_2","first-page":"30","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration for diagnosis and prediction of clinical progression in Alzheimer's disease","volume":"288","author":"Janelidze S","year":"2020","unstructured":"Janelidze S, Stomrud E, Palmqvist S, et al. Cerebrospinal fluid biomarkers of neurodegeneration for diagnosis and prediction of clinical progression in Alzheimer's disease. J Intern Med 2020; 288: 30\u201340.","journal-title":"J Intern Med"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2362"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2016.1204234"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00530-1"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21610"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c47cc2"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12756"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30071-5"},{"key":"e_1_3_4_93_2","first-page":"784","article-title":"Plasma tau: a window into the preclinical stages of Alzheimer disease?","volume":"76","author":"Mielke MM","year":"2019","unstructured":"Mielke MM, Kueider AM. Plasma tau: a window into the preclinical stages of Alzheimer disease? JAMA Neurol 2019; 76: 784\u2013786.","journal-title":"JAMA Neurol"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.1534"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2013.06.014"},{"key":"e_1_3_4_96_2","first-page":"290","article-title":"MicroRNA-455-3p as a potential biomarker for Alzheimer's disease: an update","volume":"8","author":"Kumar S","year":"2016","unstructured":"Kumar S, Reddy PH. MicroRNA-455-3p as a potential biomarker for Alzheimer's disease: an update. Front Aging Neurosci 2016; 8: 290.","journal-title":"Front Aging Neurosci"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600816R"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0304-3"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2014.05.006"},{"key":"e_1_3_4_100_2","article-title":"Blood-based biomarkers for Alzheimer's disease: plasma A\u03b240 and A\u03b242, and genetic variants","volume":"36","author":"Mielke MM","year":"2015","unstructured":"Mielke MM, Cummings JL. Blood-based biomarkers for Alzheimer's disease: plasma A\u03b240 and A\u03b242, and genetic variants. Neurobiol Aging 2015; 36: S10\u2013S17.","journal-title":"Neurobiol Aging"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8346443"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21843"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.263"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2802"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.2188"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22117"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.4.993"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv268"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809578"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550160069041"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2003.12.023"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.439"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.440"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-014-0295-9"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181b6bb95"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.06.012"},{"key":"e_1_3_4_117_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.4.538"},{"key":"e_1_3_4_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.02.016"},{"key":"e_1_3_4_119_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10265"},{"key":"e_1_3_4_120_2","doi-asserted-by":"publisher","DOI":"10.2174\/157015909787602823"},{"key":"e_1_3_4_121_2","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/756357"},{"key":"e_1_3_4_122_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052358"},{"key":"e_1_3_4_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.11.017"},{"key":"e_1_3_4_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2006.03.013"},{"key":"e_1_3_4_125_2","doi-asserted-by":"publisher","DOI":"10.1177\/2211068214559979"},{"key":"e_1_3_4_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"e_1_3_4_127_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002923"},{"key":"e_1_3_4_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)00070-3"},{"key":"e_1_3_4_129_2","first-page":"1069","article-title":"Staging \u03b2-amyloid pathology with standardized voxelwise PiB PET analyses","volume":"14","author":"Bjerke M","year":"2018","unstructured":"Bjerke M, Engelborghs S, Cavedo E, et al. Staging \u03b2-amyloid pathology with standardized voxelwise PiB PET analyses. Alzheimers Dement 2018; 14: 1069\u20131079.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_4_130_2","first-page":"727","article-title":"BDNF Rs6265 methylation and genotype interact on risk of Alzheimer's disease","volume":"30","author":"Panza F","year":"2018","unstructured":"Panza F, Lozupone M, Solfrizzi V, et al. BDNF Rs6265 methylation and genotype interact on risk of Alzheimer's disease. Aging Clin Exp Res 2018; 30: 727\u2013735.","journal-title":"Aging Clin Exp Res"},{"key":"e_1_3_4_131_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.4668"},{"key":"e_1_3_4_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.08.099"},{"key":"e_1_3_4_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.06.006"},{"key":"e_1_3_4_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.03.001"},{"key":"e_1_3_4_135_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00798"},{"key":"e_1_3_4_136_2","first-page":"931","article-title":"Management of frontotemporal dementia spectrum disorders: potential benefits and challenges of multidisciplinary care","volume":"9","author":"Jicha GA","year":"2018","unstructured":"Jicha GA, Nelson PT. Management of frontotemporal dementia spectrum disorders: potential benefits and challenges of multidisciplinary care. Front Neurol 2018; 9: 931.","journal-title":"Front Neurol"},{"key":"e_1_3_4_137_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2043-0"},{"key":"e_1_3_4_138_2","first-page":"892","article-title":"Cognitive and pathological influences of tau pathology in Lewy body disorders","volume":"89","author":"Coughlin D","year":"2021","unstructured":"Coughlin D, Xie SX, Liang M, et al. Cognitive and pathological influences of tau pathology in Lewy body disorders. Ann Neurol 2021; 89: 892\u2013906.","journal-title":"Ann Neurol"},{"key":"e_1_3_4_139_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3115"},{"key":"e_1_3_4_140_2","first-page":"439","article-title":"Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis","volume":"46","author":"Mueller C","year":"2017","unstructured":"Mueller C, Perera G, Hayes RD, et al. Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis. Age Ageing 2017; 46: 439\u2013444.","journal-title":"Age Ageing"},{"key":"e_1_3_4_141_2","first-page":"1187","article-title":"Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid \u03b2","volume":"16","author":"Mormino EC","year":"2020","unstructured":"Mormino EC, Papp KV, Rentz DM, et al. Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid \u03b2. Alzheimers Dement 2020; 16: 1187\u20131199.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_4_142_2","first-page":"684","article-title":"Trial designs used to study the effect of disease-modifying therapies on Alzheimer's disease progression: a review","volume":"10","author":"Cummings J","year":"2014","unstructured":"Cummings J, Feldman HH, Scheltens P, et al. Trial designs used to study the effect of disease-modifying therapies on Alzheimer's disease progression: a review. Alzheimers Dement 2014; 10: 684\u2013695.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_4_143_2","first-page":"162","article-title":"Retinal ganglion cells and circadian rhythms in Alzheimer's disease, Parkinson's disease, and beyond","volume":"9","author":"La Morgia C","year":"2018","unstructured":"La Morgia C, Ross-Cisneros FN, Sadun AA, et al. Retinal ganglion cells and circadian rhythms in Alzheimer's disease, Parkinson's disease, and beyond. Front Neurol 2018; 9: 162.","journal-title":"Front Neurol"},{"key":"e_1_3_4_144_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13016"},{"key":"e_1_3_4_145_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24125"},{"key":"e_1_3_4_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30367-6"},{"key":"e_1_3_4_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70136-X"},{"key":"e_1_3_4_148_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-016-0182-1"},{"key":"e_1_3_4_149_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.12.040"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877251330500","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877251330500","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877251330500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:10:20Z","timestamp":1777371020000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877251330500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":148,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1177\/13872877251330500"],"URL":"https:\/\/doi.org\/10.1177\/13872877251330500","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]}}}